BridgeMD
New treatment option for Disparities
Official title Philly CEAL- DECIDE+ Adaptation
ClinicalTrials.gov ID: NCT06732102
What this study is testing
- What it's testing
- Cardiovascular disease (CVD) disproportionately affects racial/ethnic minorities and underserved populations in Philadelphia. This study aims to evaluate the effectiveness of an enhanced community health worker (CHW) program that combines the evidence-based DECIDE self-management intervention with structured CHW consultations to improve CVD self-management skills and address social needs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Reside in Philadelphia
- Be between 35 and 75 years of age (inclusive)
- Self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
- Pre-diabetes
- Diabetes
You likely can't join if
- Does not reside in Philadelphia
- Not between 35 and 75 years of age (inclusive)
- Does not self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
- Pre-diabetes
- Diabetes
- Hypertension
See the full eligibility criteria
- Reside in Philadelphia
- Be between 35 and 75 years of age (inclusive)
- Self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
- Pre-diabetes
- Diabetes
- Hypertension
- Hyperlipidemia/ high cholesterol)
- BMI \>=30.
- Have completed an initial visit with a CEO CHW
- Have one or more unmet social needs identified in the CEO Intake Form in the following areas:
- Housing Stability,
- Food security,
- Transportation to medical appointments and/or work,
- Employment,
- Household utilities,
- Healthcare access,
- Health literacy, and
- Social support.
- Willing to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.
- Does not reside in Philadelphia
- Not between 35 and 75 years of age (inclusive)
- Does not self-report having been told by a healthcare provider that they have one or more of the following CVD-related chronic conditions:
- Pre-diabetes
- Diabetes
- Hypertension
- Hyperlipidemia/ high cholesterol)
- BMI \>=30.
- Has not completed an initial visit with a CEO CHW
- Does not have one or more unmet social needs identified in the CEO Intake Form in the following areas:
- Housing Stability,
- Food security,
- Transportation to medical appointments and/or work, employment,
- Household utilities,
- Healthcare access,
- Health literacy, and
- Social support.
- Unwilling to consent to participate in the CEAL study regular access to a mobile device to qualify for enrollment.
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.